Paul Chew

Paul Chew serves as the President of 1Rx Digipharm Advisory, LLC since March 2018, specializing in BioPharma consulting. In addition to this role, Paul holds multiple advisory and board positions, including advisory board member at ArisGlobal since June 2020, Medical Advisor at CORMEDIX INC. since May 2018, and advisory board member for the Milken Institute's Center for Public Health since April 2019. Paul is also part of the Board of Directors for CStone Pharmaceuticals and Phesi, where roles include Chief Medical Officer and advisor. Previous experience includes significant roles at US Pharmacopeia, Omada Health, and Sanofi, with a focus on improving healthcare outcomes and drug innovation. Paul earned a Doctor of Medicine degree from The Johns Hopkins University School of Medicine, after completing a Bachelor of Science in Human Biology at the same institution.